Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04183647
Other study ID # Vibration Applications
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 15, 2018
Est. completion date July 1, 2019

Study information

Verified date January 2020
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was designed as a single-blind, randomized and cross-over study to investigate and compare the acute effects of local vibration (LV) and whole-body vibration (WBV) applications on postural control in adult patients with ataxia.

The study will be included in patients aged 18-50 years, including ataxia diagnosed by the neurologist and able to walk independently. Patients with pregnancy status, epilepsy, spasticity, implant / endoprosthesis / pacemaker, benign paroxysmal positional vertigo, history of fracture in the last 6 months and other neurological diseases other than ataxia will not be included in the study. Between the applications, a washout period of one week will be given to each patient to apply both local and whole body vibrations. The order of application will be decided by the coin toss randomization method. Descriptive evaluations of the patients will be done with Mini-BESTest and Trunk Impairment Scale. Stability limits and postural sways (Bertec Balance Check ScreenerTM), gait time - distance characteristics (GAITRite), functional mobility skills (Timed Up and Go Test), and static balances (One Leg Stance Test) before, 1 minute after the application and 60 minutes after the application.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date July 1, 2019
Est. primary completion date May 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Located in the 18-50 age range, diagnosed with ataxia by the neurologist, patients who can walk independently

Exclusion Criteria:

- Patients with pregnancy status, epilepsy, spasticity, implant / endoprosthesis / pacemaker, benign paroxysmal positional vertigo, history of fracture in the last 6 months, and other neurological disorders other than ataxia

Study Design


Related Conditions & MeSH terms


Intervention

Device:
whole body vibration / local vibration
Both the whole-body vibration application and the local vibration application will be applied to the patients in our cross-over study. Between the two applications will be given a washout period of one week. Patients will be evaluated both local and whole body vibration applications, 1 minute and 60 minutes after the end of the applications. After the evaluation, the patient will be rested in the sitting position until the evaluation at the 60th minute.

Locations

Country Name City State
Turkey Hacettepe University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mini-BESTest It will be used for performance-oriented balance assessment. The test consists of 14 items and is evaluated on a score of 0-2. In the test, "0" indicates the lowest function level and "2 en indicates the highest function level. The application will be made immediately after the evaluations are completed within the same day (on average 45 min before application).
Primary Trunk Impairment Scale It will be used to evaluate trunk control. The scale has 17 items, 3 of which are static balance 10 are dynamic balance, 4 are stabilizer muscles. The total score that can be obtained is minimum "0 minimum and maximum" 23.. The application will be made immediately after the evaluations are completed within the same day (on average 30 min before application).
Primary Limits of Stability and Postural Sways Bertec Balance Check Screener (Model BP5050) force platform system will be used. This force platform will measure stability limits in 4 directions (anterior, posterior, right, left) and postural sways in 4 different conditions (firm surface -eyes open, firm surface-eyes closed, foam surface-eyes open, foam surface-eyes closed). change from baseline at 1 min and 60 min after applications.
Primary Time-Distance Characteristics of the Gait GAITRite (CIR System INC. Clifton, NJ 07012) walkway system will be used. GAITRite; It is an electronic walkway which consists of portable carpet and sensors embedded on the carpet and transfers every foot contact to the computer when individuals walk on the carpet. With GAITRite, base of support (cm), velocity (cm / s) and cadence (steps / min) parameters will be evaluated. change from baseline at 1 min and 60 min after applications.
Primary Timed Up and Go Test It will be used to evaluate functional mobility. change from baseline at 1 min and 60 min after applications.
Primary One Leg Stance Test It will be used to evaluate static balance. For the right and left lower extremities, eyes will be opened and closed in two ways. change from baseline at 1 min and 60 min after applications.
See also
  Status Clinical Trial Phase
Completed NCT03722212 - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test N/A
Completed NCT05563402 - "Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis" N/A
Terminated NCT03645265 - Rhythmic Entrainment in Bilingual Speakers With Dysarthria N/A
Completed NCT05585541 - Teleassessment in Ataxic Multiple Sclerosis
Recruiting NCT05125666 - Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection Phase 2
Recruiting NCT03881930 - Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy N/A
Completed NCT00950196 - Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia Phase 4
Completed NCT03745248 - Aerobic Exercise, Balance Training, and Ataxia N/A
Completed NCT04099914 - Validation of a Clinical Algorithm for the Diagnosis of Recessive Ataxias
Recruiting NCT03945682 - The ASsessment and Physiotherapy managEment of Ataxia in Children Following Surgical Resection of Posterior Fossa Tumour N/A
Completed NCT01428544 - Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) N/A
Completed NCT00001324 - PET Scan to Study Brain Control of Human Movement
Recruiting NCT05486806 - Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders
Completed NCT06001424 - Effect of Life Kinetik Training on Lower Limb Coordination in Ataxic Patients N/A
Completed NCT00244361 - Effectiveness of Rituximab in Pediatric OMS Patients. Phase 1/Phase 2
Completed NCT00692861 - Autoimmunity in Neurologic Complications of Celiac Disease
Recruiting NCT05885282 - Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises N/A
Recruiting NCT02841553 - Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
Completed NCT05621200 - Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia N/A
Completed NCT02829268 - A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome Phase 1/Phase 2